NDC00270-1315-35: IOPAMIDOL INJECTION.
The IOPAMIDOL INJECTION is a the manufacturer industrial component. Key specifications include administration: INTRAVASCULAR, primary_container_type: BOTTLE, pharmaceutical_vehicle_type: AQUEOUS, total_primary_container_quantity: 10, primary_container_content_quantity: 100.0 MILLILITERS, part_name_assigned_by_controlling_agency: IOPAMIDOL INJECTION, 100ML BOTTLE, 10S. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-285-0170, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAVASCULAR |
| primary_container_type | BOTTLE |
| pharmaceutical_vehicle_type | AQUEOUS |
| total_primary_container_quantity | 10 |
| primary_container_content_quantity | 100.0 MILLILITERS |
| part_name_assigned_by_controlling_agency | IOPAMIDOL INJECTION, 100ML BOTTLE, 10S |
| NSN | 6505-01-285-0170 |
| ADMINISTRATION | INTRAVASCULAR |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.0 MILLILITERS |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | INDICATED FOR ANGIOGRAPHY THROUGHOUT THE CARDIOVASCULAR SYSTEM; NOT FOR INTRATHECAL USE; STABLE, AQUEOUS, STERILE, AND NONPYROGENIC SOLUTIONS FOR INTRAVASCULAR ADMINISTRATION; ISOVUE-300, 10 100 ML SINGLE DOSE BOTTLE; STORE AT 20C TO 25C (68F TO 77F); (SEE USP); PROTECT FROM LIGHT; 61 PERCENTAGE, W/V IOPAMIDOL ACTIVE INGREDIENT. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | IOPAMIDOL INJECTION, 100ML BOTTLE, 10S |
| PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
| TOTAL PRIMARY CONTAINER QUANTITY | 10 |